The Current Positioning of Augmentation Enterocystoplasty in the Treatment for Neurogenic Bladder
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Augmentation enterocystoplasty (AEC) is a surgical procedure in which the bladder is enlarged using an intestinal segment in patients with lower urinary tract dysfunction who fail to achieve satisfactory results with all conservative treatments. Currently, surgical materials and procedures, concomitant correction of upper urinary tract abnormalities, or bladder neck reconstruction may vary depending on the experience and preferences of the surgeons. AEC has been proven to be successful with respect to surgical goals, such as achieving urinary continence, improving quality of life, and preserving the upper urinary tract over the long term. The advantage of AEC over intravesical injection of botulinum toxin—a more recent and less invasive procedure—is that the prevention of upper urinary tract damage and the improvement of urinary incontinence are more reliably guaranteed, especially considering that these surgical effects are permanent. Compared to less invasive treatments, the quality of life of patients after surgery is also much higher, and AEC may be more cost-effective in the long run. Thus, in patients with neurogenic bladder, AEC is still the gold standard surgical procedure with strong evidence in support of its efficacy. In this article, the indications, surgical methods, possible complications, long-term follow-up, and current positioning of AEC in lower urinary tract dysfunction is discussed.
Abstract
Augmentation enterocystoplasty (AEC) is a surgical procedure in which the bladder is enlarged using an intestinal segment in patients with lower urinary tract dysfunction who fail to achieve satisfactory results with all conservative treatments. Currently, surgical materials and procedures, concomitant correction of upper urinary tract abnormalities, or bladder neck reconstruction may vary depending on the experience and preferences of the surgeons. AEC has been proven to be successful with respect to surgical goals, such as achieving urinary continence, improving quality of life, and preserving the upper urinary tract over the long term. The advantage of AEC over intravesical injection of botulinum toxin—a more recent and less invasive procedure—is that the prevention of upper urinary tract damage and the improvement of urinary incontinence are more reliably guaranteed, especially considering that these surgical effects are permanent. Compared to less invasive treatments, the quality of life of patients after surgery is also much higher, and AEC may be more cost-effective in the long run. Thus, in patients with neurogenic bladder, AEC is still the gold standard surgical procedure with strong evidence in support of its efficacy. In this article, the indications, surgical methods, possible complications, long-term follow-up, and current positioning of AEC in lower urinary tract dysfunction is discussed.
참고문헌 (35)
- Rutkowski M, "Zur Methode der Harnblasenplastik", Zbl Chir, 16, pp.473~478 (1899)
- Couvelaire R, "La petite vessie des tuberculeux genito-urinairses: essai de classification, places et variants des cystointestinoplasties", J Urol Medicale Chir, 56, pp.381~434 (1950)
- Lapides J, "Clean, intermittent selfcatheterization in the treatment of urinary tract disease", J Urol, 107, pp.458~461 (1972)
- Bandi G, "Comparison of traditional enterocystoplasty and seromuscular colocystoplasty lined with urothelium", J Pediatr Urol, 3, pp.484~489 (2007)
- Cameron AP, "Glenn’s urologic surgery", pp.118~124 (2010), Wolters Kluwer
- Cartwright PC, "Hinman’s atlas of urologic surgery", pp.461~464 (2018), Elsevier
- Dahl DM, "Campbell-Walsh urology", pp.2281~2316 (2016), Elsevier
- 이한이, "Is Concomitant Bladder Neck Reconstruction Necessary in Neurogenic Incontinent Patients Who Undergo Augmentation Cystoplasty?", Investigative and Clinical Urology, 54(1), pp.42~47 (2013), 대한비뇨의학회
- Grimsby GM, "Long-term outcomes of bladder neck reconstruction without augmentation cystoplasty in children", J Urol, 195, pp.155~161 (2016)
- Simforoosh N, "Is ureteral reimplantation necessary during augmentation cystoplasty in patients with neurogenic bladder and vesicoureteral reflux", J Urol, 168(4 Pt 1), pp.1439~1441 (2002)
- Studer UE, "Three years’experience with an ileal low pressure bladder substitute", Br J Urol, 63, pp.43~52 (1989)
- Abol-Enein H, "Further clinical experience with the ileal W-neobladder and a serous-lined extramural tunnel for orthotopic substitution", Br J Urol, 76, pp.558~564 (1995)
- Krebs J, "Functional outcome of supratrigonal cystectomy and augmentation ileocystoplasty in adult patients with refractory neurogenic lower urinary tract dysfunction", Neurourol Urodyn, 35, pp.260~266 (2016)
- Medel R, "Urinary continence outcomes after augmentation ileocystoplasty as a single surgical procedure in patients with myelodysplasia", J Urol, 168, pp.1849~1852 (2002)
- Khastgir J, "Surgical and patient reported outcomes of ‘clam’ augmentation ileocystoplasty in spinal cord injured patients", Eur Urol, 43, pp.263~269 (2003)
- Shekarriz B, "Surgical complications of bladder augmentation : comparison between various enterocystoplasties in 133 patients", Urology, 55, pp.123~128 (2000)
- Herschorn S, "Patient perspective of long-term outcome of augmentation cystoplasty for neurogenic bladder", Urology, 52, pp.672~678 (1998)
- Perrouin-Verbe MA, "Long-term functional outcomes of augmentation cystoplasty in adult spina bifida patients : a single-center experience in a multidisciplinary team", Neurourol Urodyn, 38, pp.330~337 (2019)
- Shahbaz Mehmood, "Long-term Outcomes of Augmentation Cystoplasty in a Pediatric Population With Refractory Bladder Dysfunction: A 12-Year Follow-up Experience at Single Center", International Neurourology Journal, 22(4), pp.287~294 (2018), 대한배뇨장애요실금학회
- Krishna A, "Ileocystoplasty in children : assessing safety and success", Eur Urol, 27, pp.62~66 (1995)
- Hoen L’, "Long-term effectiveness and complication rates of bladder augmentation in patients with neurogenic bladder dysfunction : a systematic review", Neurourol Urodyn, 36, pp.1685~1702 (2017)
- Maldonado N, "Thirty-day hospital readmissions after augmentation cystoplasty : a nationwide readmissions database analysis", J Pediatr Urol, 14, pp.533.e1~533.e9 (2018)
- Cheng KC, "Augmentation cystoplasty : urodynamic and metabolic outcomes at 10-year follow-up", Int J Urol, 22, pp.1149~1154 (2015)
- Higuchi TT, "Augmentation cystoplasty and risk of neoplasia: fact, fiction and controversy", J Urol, 184, pp.2492~2496 (2010)
- Soergel TM, "Transitional cell carcinoma of the bladder following augmentation cystoplasty for the neuropathic bladder", J Urol, 172, pp.1649~1651 (2004)
- Kuo HC, "Effect of repeated detrusor onabotulinumtoxinA injections on bladder and renal function in patients with chronic spinal cord injuries", Neurourol Urodyn, 30, pp.1541~1545 (2011)
- Biers SM, "The past, present and future of augmentation cystoplasty", BJU Int, 109, pp.1280~1293 (2012)
- Anquetil C, "Botulinum toxin therapy for neurogenic detrusor hyperactivity versus augmentation enterocystoplasty : impact on the quality of life of patients with SCI", Spinal Cord, 54, pp.1031~1035 (2016)
- Costa P, "Quality of life in spinal cord injury patients with urinary difficulties. Development and validation of qualiveen", Eur Urol, 39, pp.107~113 (2001)
- El-Azab AS, "The satisfaction of patients with refractory idiopathic overactive bladder with onabotulinumtoxinA and augmentation cystoplasty", Arab J Urol, 11, pp.344~349 (2013)
- Myers JB, "The effects of augmentation cystoplasty and botulinum toxin injection on patient-reported bladder function and quality of life among individuals with spinal cord injury performing clean intermittent catheterization", Neurourol Urodyn, 38, pp.285~294 (2019)
- Mohee A, "Long-term outcome of the use of intravesical botulinum toxin for the treatment of overactive bladder(OAB)", BJU Int, 111, pp.106~113 (2013)
- Padmanabhan P, "Five-year cost analysis of intra-detrusor injection of botulinum toxin type A and augmentation cystoplasty for refractory neurogenic detrusor overa ctivity", World J Urol, 29, pp.51~57 (2011)
- Shreck E, "Indications for augmentation cystoplasty in the era of onabotulinumtoxinA", Curr Urol Rep, 17, pp.27~ (2016)
- Shu-Yu Wu, "Long-term Outcomes of Augmentation Enterocystoplasty in Patients With End-Stage Bladder Diseases: A Single-Institute Experience Involving 102 Patients", International Neurourology Journal, 21(2), pp.133~138 (2017), 대한배뇨장애요실금학회